Atlas Trials

Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma

Clinical trial NCT07168473 · RECRUITING

Trial details

NCT number
NCT07168473
Sponsor
Daewon Pharmaceutical Co., Ltd.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Perennial Allergic Rhinitis Accompanied by Asthma
Start date
2024-09-09
Primary completion
2026-08-31
Enrollment
274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.